目次

Chapter- 1: Introduction
Study Goals and Objectives
Reasons for Doing This Study
What's New in This Update?
Scope of Report
Methodology and Information Sources
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter- 2: Summary and Highlights
Table Summary : Global Market for CNS Biomarkers, by Application, Through 2027
Figure Summary : Global Market for CNS Biomarkers, by Application, 2019-2027

Chapter- 3: Market and Technology Background
Overview of Biomarkers
Classification of Biomarkers
Types of Biomarkers
Biomarker Discovery, Verification and Validation
Overview of Central Nervous System (CNS)

Chapter- 4: Market Dynamics
Drivers
Restraints

Chapter- 5: Market Breakdown by Disease
Market Overview
Alzheimer's Disease (AD)
Key Biomarkers of AD
Parkinson's Disease (PD)
Key Biomarkers of PD
Multiple Sclerosis (MS)
Key Biomarkers of MS
Amyotrophic Lateral Sclerosis (ALS)
Frontotemporal Dementia (FTD)
Key Biomarkers of ALS and FTD
Traumatic Brain Injury (TBI) or Concussion
Traumatic Spinal Cord Injury (SCI)
Key Biomarkers/Hallmarks of TBI or SCI
Other Diseases
Global Market for CNS Biomarkers by Disease

Chapter- 6: Market Breakdown by Application
Market Overview
Life Science Research
Drug Discovery and Development
Clinical Diagnostics
Personalized Medicine
Precision Health Screening/Disease Risk Assessment
Global Market for CNS Biomarkers, by Application

Chapter- 7: Market Breakdown by Technology Type
Market Overview
Proteomics
Imaging
Genomics
Global Market for CNS Biomarkers, by Technology Type

Chapter- 8: Market Breakdown by Biomarker Type
Key Biomarkers of Neurodegeneration
Key Biomarkers of Traumatic Brain and Spinal Injuries
Key Biomarker Targets for Neuroinflammation
Global CNS Biomarkers Market by Biomarker Type

Chapter- 9: Market Breakdown by Region
Global Market for CNS Biomarkers by Region
North America
Europe
Asia-Pacific
Rest of the World (RoW)

Chapter- 10: Impact of COVID-19
Overview
Impact on CNS Biomarkers Market

Chapter- 11: Competitive Landscape
Overview
Product Launches/Approvals
Collaborations/Partnerships
SWOT Analysis for Global CNS Biomarker Industry

Chapter- 12: Emerging Products/Technologies in the Market
Blood Tests for CNS Biomarkers
Focus on Tau Protein
Digital Biomarkers
Emerging Clinically Relevant CNS Biomarker Candidates

Chapter- 13: Company Profiles
ABBOTT LABORATORIES LTD.
BIOMERIEUX S.A.
BIO-RAD LABORATORIES, INC.
C?N DIAGNOSTICS, LLC
DIADEM SPA
EISAI CO. LTD.
ELI LILLY AND CO.
F. HOFFMANN-LA ROCHE AG
H.U. GROUP HOLDINGS INC.
LABORATORY CORP. OF AMERICA (LABCORP)
MERCK KGAA
PERKINELMER INC.
QUANTERIX CORP.
QUEST DIAGNOSTICS INC.
SHIMADZU CORP.
SIEMENS HEALTHINEERS AG
SYSMEX CORP.
THERMO FISHER SCIENTIFIC INC.